Literature DB >> 10066435

IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2.

H Suzuki1, T Chiba, M Kobayashi, M Takeuchi, T Suzuki, A Ichiyama, T Ikenoue, M Omata, K Furuichi, K Tanaka.   

Abstract

Destruction of the transcriptional inhibitor IkappaB by the ubiquitin (Ub) system is required for signal-dependent activation of the multifunctional transcriptional factor NF-kappaB, but details of this ubiquitination are largely unknown. We report here that the IkappaBalpha-ubiquitin ligase (IkappaBalpha-E3) is an SCF-like complex containing Skp1, cullin-1, and two homologous F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2. Intriguingly, all these components are cooperatively recruited to bind to a phosphorylated IkappaBalpha (pIkappaBalpha) produced by tumor necrosis factor-alpha (TNF-alpha) stimulation. IkappaBalpha-E3 bound to pIkappaBalpha catalyzed in vitro ubiquitination of pIkappaBalpha in the presence of ATP, Ub, and E1-activating and E2-conjugating enzymes. Forced expression of betaTrCP1 and betaTrCP2 resulted in dramatic augmentation of the in vitro polyubiquitination activity of IkappaBalpha-E3. These results indicate that the long-sought IkappaBalpha-E3 is an SCF-like complex consisting of multiple proteins which are coordinately assembled during phosphorylation of IkappaBalpha in response to external signals. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066435     DOI: 10.1006/bbrc.1999.0289

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase in fission yeast.

Authors:  F Osaka; M Saeki; S Katayama; N Aida; A Toh-E; K Kominami; T Toda; T Suzuki; T Chiba; K Tanaka; S Kato
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 3.  The jasmonate signal pathway.

Authors:  John G Turner; Christine Ellis; Alessandra Devoto
Journal:  Plant Cell       Date:  2002       Impact factor: 11.277

Review 4.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

5.  Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.

Authors:  V Heissmeyer; D Krappmann; E N Hatada; C Scheidereit
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Crumbs promotes expanded recognition and degradation by the SCF(Slimb/β-TrCP) ubiquitin ligase.

Authors:  Paulo Ribeiro; Maxine Holder; David Frith; Ambrosius P Snijders; Nicolas Tapon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

7.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

9.  Modulation of SCF beta-TrCP-dependent I kappaB alpha ubiquitination by hydrogen peroxide.

Authors:  Sami Banerjee; Jaroslaw W Zmijewski; Emmanuel Lorne; Gang Liu; Yonggang Sha; Edward Abraham
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

10.  Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.

Authors:  Prakash Radhakrishnan; Vashti C Bryant; Elizabeth C Blowers; Rajkumar N Rajule; Nagsen Gautam; Muhammad M Anwar; Ashley M Mohr; Paul M Grandgenett; Stephanie K Bunt; Jamie L Arnst; Subodh M Lele; Yazen Alnouti; Michael A Hollingsworth; Amarnath Natarajan
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.